XML 17 R9.htm IDEA: XBRL DOCUMENT v3.20.1
NOTE 3 - EQUITY TRANSACTIONS
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
NOTE 3 - EQUITY TRANSACTIONS

NOTE 3 - EQUITY TRANSACTIONS

 

The Company has 500,000,000 shares of common stock authorized with a par value of $0.0001. 25,000,000 shares of common stock were issued to the founder of the Company on incorporation.

 

During the year ended December 31, 2018, the Company sold a total of 63,800 shares of its common stock (and 63,800 Warrants) to investors at a price of $0.50 per share or $31,900 total.

 

On August 1, 2018, the Company issued a total of 10,475,000 shares of its common stock to one consulting firm entity and nine individuals for consulting services to be rendered to the Company pursuant to Consulting Agreements dated August 1, 2018 for terms ranging from 3 to 6 months. The shares were valued at $0.50 per share or $5,237,500 total which were being expensed as consulting and business development expenses on the statement of operations over the terms of the respective Consulting Agreements. $4,408,333 (of the $5,237,500 total) has been expensed in the year ended December 31, 2018, and $829,167 (of the $5,237,500 total) has been expensed in the year ended December 31, 2019.

 

On August 1, 2018, the Company issued a total of 250,000 shares of its common stock for legal services rendered to the Company. The shares were valued at $0.50 per share or $125,000 total which is included in professional and accounting fees on the statement of operations for the year ended December 31, 2018.

 

On March 12, 2019, the Company sold 200,000 shares of its common stock (and 200,000 Warrants) to an investor at a price of $0.50 per share or $100,000 total.

 

Warrants

 

A summary of Warrants activity for the years ended December 31, 2018 and 2019 follows:

 

Balance, January 1, 2018 150,000
Issued in 2018 63,800
Balance, December 31, 2018 213,800
Issued in 2019 200,000
Expired in 2019 (150,000)
Balance, December 31, 2019 263,800

 

Each Warrant is exercisable into shares of our common stock at an exercise price of $1.00 per share and expires two years from the date of its issuance.